Le Centre hospitalier universitaire de Caen Normandie est un hôpital français au double statut universitaire et régional situé à Caen en Normandie. D'une capacité totale de 1 495 lits, c'est le principal établissement hospitalier de Caen, et l'un des centres hospitaliers référent pour la Normandie.

During the past decade, CHU de Caen conducted 328 clinical trials. In the 10-year time frame, 328 clinical trials started and 20 clinical trials were completed, i.e. on average, 6.1% percent of trials that started reached the finish line to date. In the past 5 years, 150 clinical trials started and 11 clinical trials were completed. i.e. 7.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHU de Caen" #1 sponsor was "University Hospital, Caen" with 73 trials, followed by "Nantes University Hospital" with 21 trials sponsored, "Centre Francois Baclesse" with 19 trials sponsored, "University Hospital, Lille" with 17 trials sponsored and "Centre Hospitalier Universitaire, Amiens" with 17 trials sponsored. Other sponsors include 328 different institutions and companies that sponsored additional 149 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU de Caen" #1 collaborator was "Ministry of Health, France" with 21 trials as a collaborator, "National Cancer Institute, France" with 11 trials as a collaborator, "Novespace" with 7 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 5 trials as a collaborator and "Intergroupe Francophone de Cancerologie Thoracique" with 4 trials as a collaborator. Other collaborators include 263 different institutions and companies that were collaborators in the rest 217 trials.

According to Clinical.Site data, the most researched conditions in "CHU de Caen" are "Multiple Myeloma" (11 trials), "Healthy Volunteers" (9 trials), "Acute Myeloid Leukemia" (8 trials), "Multiple Sclerosis" (8 trials) and "Myelodysplastic Syndromes" (7 trials). Many other conditions were trialed in "CHU de Caen" in a lesser frequency.

Most popular intervention types in "CHU de Caen" are "Drug" (190 trials), "Other" (113 trials), "Device" (65 trials), "Procedure" (60 trials) and "Biological" (20 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (31 trials), "radiation therapy" (8 trials), "placebo" (7 trials), "Dexamethasone" (6 trials) and "Rituximab" (5 trials). Other intervention names were less common.

The vast majority of trials in "CHU de Caen" are 447 trials for "All" genders, 23 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "CHU de Caen". 11 are not yet recruiting, 106 are recruiting, 39 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 211 completed trials in CHU de Caen, 1 suspended trials, and 31 terminated clinical trials to date.

Out of the total trials that were conducted in CHU de Caen, 11 "Phase 1" clinical trials were conducted, 73 "Phase 2" clinical trials and 124 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 17 trials, and there were also 126 trials that are defined as “Not Applicable".

CHU de Caen has several departments that took part in Clinical trials: "Hopital Cote De Nacre; Unite Neurologie Generale" - 9 trials, "Service de Cardiologie" - 2 trials, "Hopital Cote De Nacre; Gastro Enterologie" - 3 trials, "Hopital Clemenceau; Nephrologie Hemodialyse" - 2 trials